chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Acid taste in mouth that won't go away.; White layer in tongue that won't brush away (similar to thrush); scalloped looking tongue with ridges around perimeter of tongue from swelling; This is a spontaneous report from a non-contactable consumer or other non hcp reported for herself. A 32-year-old female (not pregnant) patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EL9267), via an unspecified route of administration, administered in Arm Right on 12Feb2021  as dose number unknown, single (age at vaccination 32-year-old) for covid-19 immunisation. Medical history included known allergies: Sulfa from an unknown date. Concomitant medication(s) included sertraline hydrochloride (ZOLOFT) taken for an unspecified indication, start and stop date were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient was not pregnant at the time of vaccination. The patient experienced acid taste in mouth that won't go away, white layer in tongue that won't brush away, scalloped looking tongue with ridges around perimeter of tongue from swelling on 12Feb2021 21:00. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 15Feb2021 (covid test result=Negative). Therapeutic measures were taken as a result of events. The outcome for all events was recovering.
Injection given 8/4/11. On 8/31/11 pt. presented with a raised red area 3/4" in diameter with a reddened area surrounding it that measures 2 1/2 x 1 3/4". CLARITIN 10mg daily ordered & cold compresses.
heart palpitations; This is a spontaneous report from a non-contactable consumer, the patient. A 28-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 21Mar2021 (at the age of 28-year-old) as a single dose for COVID-19 immunisation. Medical history included anemia. The patient did not have allergies to medications, food, or other products. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 23Mar2021 the patient experienced heart palpitations, started two days after vaccine and lasted until a week later. The patient was also on period but not sure if that was related. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as the result of adverse events. The clinical outcome of the events heart palpitations was recovered on an unknown date in 2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
OCCATIONAL CHEST PAIN AND SHORTNESS OF BREATH STARTED A COUPLE OF WEEKS AFTER FIRST VACINATION. THIS WAS REPORTED DURING A PRIMARY CARE VISIT.  AFTER SECOND VACINATION THE CEST PAIN AND SHORTNESS OF BREATH BECAME MORE SEVERE. A FEW WEEKS AFTER THE SECOND VACINE I WENT TO THE EMERGENCY ROOM DUE TO CHEST PAIN AND SHORTNESS OF BREATH.  CHEST XR SHOWED "Heart is upper limits normal mildly enlarged but stable."  CHEST XR TAKEN IN JUNE AS PART OF BARIATRIC  PROGRAM SHOWED HEART AND LUNGS NORMAL.  I HAVE NEVER HAD CHEST PAINT AND SHORTNESS OF BREATH LIKE THIS AND UP UNTIL THIS POINT HAVE USED THE TREADMILL AT HOME REGULARLY.
At 2PM 1/9/2022 the patient began experiencing an itchy rash on her torso. Over the next 24 hours she developed itchy spots over her whole body. Her sister received the same vaccine (pfizer booster) and was experiencing similar symptoms with the same timetable. The patient did not have any issues with the first two vaccines; she also reported starting to use a new body lotion within the two weeks prior to the symptoms starting.
Information has been received from a nurse concerning a 17 year old female daughter of a physician that was vaccinated on 19-SEP-2007, with RECOMBIVAX HB. On 19-SEP-2007, she experienced shortness of breath and hives. She received medical care at the physicians office. Details of the treatment were not provided, but she reportedly fully recovered. The vaccine series was discontinued after the first dose. A product quality complaint was not reported. Additional information has been requested.
Starting having severe leg cramps  Lost 26 lbs after vomiting every meal taken by ambulance  told his sugar is over 600 never had diabetes or diverticulitis was told he now has two new conditions requires insulin was in ICU told no covid
Woke unable to breathe. Physically i could draw air in and out but I still felt it was never enough. I was woken with this feeling. It passed after 1 hour. Since then I have had chronic pain in my upper chest (bronchial tubes) and was diagnosed at an urgent care with Bronchitis.
Lips became numb, throat began to tickle, chest became extremely tight, face and neck became beat red and at that point my throat began to close and I could not breathe.
Left leg became very painful to walk on with noticeable limp. Then 5 days later still limping and complaining of leg pain and lower back pain, and red rash looking splotches showed on left leg. On exam the patient had classical shingles in an I2 distribution that started in the lower back and wound around the left leg with clusters of vesicles in that pattern. In retrospect, this has probably been a shingles case. Exposure has only been through a vaccine done about 3 years ago.
Overnight 4 Feb. Right back muscle pain. dinner plate sized. Felt like ribs were broken also 4 Feb Pain immobilzed me on the couch 5 Feb Up and around a bit. Could sit on chair. 6 Feb still better. could drive a car. 7-9 Feb mostly gone except in torso areas that were not originally involved 10 Feb Fully recovered. Throughout all just cranked up the ibuprofen
Chills, achiness, very sore arms, especially left art from Shingrix, redness about 4 inch around injection site on left arm.
Administered vaccine that was stored at temperature between -80 degree F to -84 degree F; Administered vaccine that was stored at temperature between -80 degree F to -84 degree F; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) and POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 076C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Nov-2021 at 3:38 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 23-Nov-2021 at 3:38 PM, the patient experienced PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F). On an unknown date, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F). At the time of the report, PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) and POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information was provided.  It was reported that the vaccine was at frozen storage condition at the time of the temperature excursion. Excursion duration was 1 month.  On 19-Nov-2021, the Moderna COVID-19 vaccine vial went from the super cold freezer to the refrigerator. The vaccine was returned to the freezer/refrigerator/ultra cold freezer, or maintained at room temperature.  No vaccine state changes were noticed. The vaccine was never refrozen. None of the vials were punctured. No previous temperature excursion issues had happened.  The patient was given doses from a vial that were stored in an ultracold freezer which is colder than they should have been. No treatment medication information was provided.   This case was linked to MOD-2021-402935 (Patient Link).
Reddened area approx. 4 1/2 cm wide and 2 cm long, warm to the touch surrounding injection of the upper left arm.
In November 2015 (I am unsure of the date so I just picked one) I received a flu vaccine from my employer. I did not want one, but I was told it was mandatory. Unfortunately I did not know to read the manufacturers' insert. I developed neurological complications about 72 hours afterward - tingling of the hands and feet etc. I progressively declined from there. I presently have severe multiple sclerosis symptoms, and have had them continually with zero relief since this incident.
Patient describes pain in left arm since time of injection. She has difficulty lifting her arm. She says pain subsides with ibuprofen.
Started itching around 3pm day of administration (given about 1030-1045am) noticed large hives around 5pm. Next morning got a prescription for prednisone. On 5/7/07 mostly cleared - although still has some hives and itching.
Sensitive to touch around heart region, pleuritic chest pain (only near heart), shortness of breath during normal daily routines, extreme fatigue, nausea, weak and vertigo.
4 days after first vaccine started to get left cheek and left arm numbness without weakness. Also had left vision spotting. Different pattern than pts usual migraine
Developed a fever of 102.4 degrees, then swelling and redness of arm. Sent to Urgent care and diagnosed with cellulitis and placed on antibiotics.
Hair loss, with increased shedding and obvious signs of hair loss at temples, behind ears and nape of neck.
Moderna administered on 11/10/2021 to patient from a vial that was opened on approximately 11am.
COVID-19  Cough  Severe headache  Sinus congestion  Loss of smell and taste
High fever (102°) for 12 hrs. Severe vertigo (spinning and disequilibrium)  w nausea and vomiting for 42 hours. Ended up in ER: treated for dehydration and administered Zofran and meclazine. Still taking 10 mg meclazine 3xs daily.
Pt C/O redness, itching, and feeling hot. Pt given 25 mg PO Benadryl at 9:00AM, pt's mother called and at 9:25 AM, pt's mother said to give her another 25 mg dose of Benadryl.
On 1/11/21, site became swollen, red and itchy. Diameter of a pingpong ball, hard with induration of a few centimeters   Starting the evening of 1/10/21  Also with localized reaction, significant nasal congestion, watery eyes , pressure in both ears and more shortness of breath than typical with my asthma.
This spontaneous report was received from a registered nurse refers to a patient of unknown age who on 07-DEC-2012 was vaccinated with an improperly stored dose of (Merck) PROQUAD (dose and route unknown), Lot #: H015623, Exp date: 21-FEB-2014. No other co-suspects were reported. No concomitant medications were reported. No adverse event reported. Patient's outcome was unknown. This is one of several reports from the same source. Additional information is not expected.
CONFIRMED IMMUNOLOGICAL VACCINE FAILURE; This spontaneous report received from a patient concerned a 58 year old white not Hispanic or Latino male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 205A21A, and expiry: UNKNOWN) dose was not reported, 1 total, administered on 01-JUN-2021 to left arm for prophylactic vaccination. No concomitant medications were reported.  On 15-JUL-2021, the patient did Sars-Cov-2 Antibody(Ab), IgGX test which was negative (confirmed immunological vaccine failure) and the patient stated that he was worried that he received a fraudulent dose of the vaccine. The patient said that he was additionally suspicious because the pharmacy was a very small facility that he found on the CDC website at a time where no other location had the Janssen Covid-19 Vaccine. The patient also said that he rebooked his original appointment to several weeks later and the facility still had a supply, during a time when other facilities were running out within days. The patient stated that he did not see the dose get drawn up in front of him from a vial and also he did not experienced any side effects. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of confirmed immunological vaccine failure was not reported. This report was serious (Other Medically Important Condition). This report was associated with a product quality complaint:90000191025.; Sender's Comments: V0:20210852955-COVID-19 VACCINE AD26.COV2.S-Confirmed Immunological vaccine failure. This event is considered not related. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event than the drug. Specifically: SPECIAL SITUATIONS
All patients received Expired Moderna COVID-19 vaccine from a vial that was stored in the refrigerator beyond 30 days; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (All patients received Expired Moderna COVID-19 vaccine from a vial that was stored in the refrigerator beyond 30 days) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027H21B) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (All patients received Expired Moderna COVID-19 vaccine from a vial that was stored in the refrigerator beyond 30 days). On 30-Dec-2021, EXPIRED PRODUCT ADMINISTERED (All patients received Expired Moderna COVID-19 vaccine from a vial that was stored in the refrigerator beyond 30 days) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported.   Treatment information was not reported.
Within just a couple minutes, I felt tightness in my chest.  A few minutes later I felt tightness in my throat.  This is the same affect I have when I breath in cooked, steaming mushrooms on pizza or other cooked foods. I informed a nurse nearby about it and she had another nurse  come over and talk to me.  They asked  me if I wanted to go to the Emergency Room at the hospital and I declined, thinking it would subside, and because I was there with a woman whom I am one of her home care providers.. I did relaxation exercises and drank water to relax and it helped a little but after leaving, I went to a pharmacy and purchased Benadryl and took a 20ml dose.  Within about 30 minutes I was feeling better and the next day my chest felt fine but my throat still bothered me; I assumed my throat muscles were still sore from the swelling.
shingles, had first shingles vaccine, second one in June; pain unbearable; covered the left side of body including the left arm; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included COVID-19 VACCINE (COVID-19 BOOSTER) for prophylaxis.   The patient's past medical history included shingles (1st episode occured on an unknown date).   On an unknown date, the patient received the 1st dose of Shingles vaccine and COVID-19 BOOSTER. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced shingles, pain and pain in arm. The patient was treated with antivirals nos (Antiviral (Drug Name Unknown)). On an unknown date, the outcome of the shingles, pain and pain in arm were not recovered/not resolved.   It was unknown if the reporter considered the shingles, pain and pain in arm to be related to Shingles vaccine.     Additional Information:  Receipt Date: 29-Apr-2022 Reporter's comments: This case was received from interactive digital media by the patient. The patient had first shingles vaccine and would get the second one in June. The patient got second case of shingles three weeks after a Covid-19 booster. Not sure if it was connected though the doctor said it was a possibility. The patient had a severe debilitating case that covered the left side of body including the left arm. Antiviral medications did not help at all. Pain was unbearable. The patient still had a great deal of pain months later. No end in sight. The reporter possibley considered the shingles, weakness and pain to be related to COVID-19 BOOSTER.
I had a fever for about 3-4 days, coughing, and nasal congestion. I also had a really sore throat which is how it started out and it lasted for about 3-4 days.
1st dose ,October 13, 2021,  side effects included pain in left arm 2nd dose,  November 3, 2021, side effects began several minutes after the injection, with a mild constriction of the throat muscles.  Then several hours after the injection,  severe pain in right arm, to restrict movement in right arm.  Severe head pain that was unrelieved by anti dolorifc meds. Right arm was cold to touch. The evening after the injection several episodes of dizziness and  nausea were noted. Evening of November 5th, chest pain was observed for several hours, and a healthcare visit was made.  Noted an irregularity of menstrual cycle, otherwise normal Noted a decrease in short term memory.
Redness and swelling (around DTP vaccine puncture) that developed during 48 hours after vaccination. Diameter 13cm on 9/13/02.
swelling on collarbone; Swelling of lymph nodes under armpit; tiredness; This spontaneous case was reported by a consumer and describes the occurrence of JOINT SWELLING (swelling on collarbone), LYMPHADENOPATHY (Swelling of lymph nodes under armpit) and FATIGUE (tiredness) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029A21A and 013M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced JOINT SWELLING (swelling on collarbone), LYMPHADENOPATHY (Swelling of lymph nodes under armpit) and FATIGUE (tiredness). The patient was treated with IBUPROFEN at a dose of 1 dosage form. At the time of the report, JOINT SWELLING (swelling on collarbone), LYMPHADENOPATHY (Swelling of lymph nodes under armpit) and FATIGUE (tiredness) outcome was unknown.            No concomitant medications were reported.   This case was linked to MOD-2021-035950 (Patient Link).   Reporter did not allow further contact
Red mark around neck; Red mark turned into red blotch around 6 inch wide; Blisters appeared or like small little pimples; Eyes watered continuously; Eye lids sore; Eye lids swollen; hard to focus and could not read; having an urge to rub the eyes while sleeping; Itchy; skin around the eyes looks flaked and puckered; pain to touch; feels like there is grit in his eye; Chills but no fever; Sick; Dizziness; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ILLNESS (Sick), DIZZINESS (Dizziness), ERYTHEMA (Red mark around neck), ERYTHEMA (Red mark turned into red blotch around 6 inch wide) and BLISTER (Blisters appeared or like small little pimples) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032MZOA) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Cholesterol high and Prostate examination abnormal. Concomitant products included PRAVASTATIN, FINASTERIDE, VITAMINS NOS (DAILY VITAMINS) and ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.   On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-Mar-2021, the patient experienced ILLNESS (Sick) and DIZZINESS (Dizziness). 21-Mar-2021, the patient experienced CHILLS (Chills but no fever). On an unknown date, the patient experienced ERYTHEMA (Red mark around neck), ERYTHEMA (Red mark turned into red blotch around 6 inch wide), BLISTER (Blisters appeared or like small little pimples), LACRIMATION INCREASED (Eyes watered continuously), EYE PAIN (Eye lids sore), SWELLING OF EYELID (Eye lids swollen), VISION BLURRED (hard to focus and could not read), OCULAR DISCOMFORT (having an urge to rub the eyes while sleeping), PRURITUS (Itchy), SKIN DISCOMFORT (skin around the eyes looks flaked and puckered), EYE PAIN (pain to touch) and OCULAR DISCOMFORT (feels like there is grit in his eye). The patient was treated with NYSTATIN (STATIN [NYSTATIN]) at an unspecified dose and frequency. At the time of the report, ILLNESS (Sick), DIZZINESS (Dizziness), ERYTHEMA (Red mark around neck), ERYTHEMA (Red mark turned into red blotch around 6 inch wide), BLISTER (Blisters appeared or like small little pimples), LACRIMATION INCREASED (Eyes watered continuously), EYE PAIN (Eye lids sore), SWELLING OF EYELID (Eye lids swollen), VISION BLURRED (hard to focus and could not read), OCULAR DISCOMFORT (having an urge to rub the eyes while sleeping), PRURITUS (Itchy), SKIN DISCOMFORT (skin around the eyes looks flaked and puckered), EYE PAIN (pain to touch), OCULAR DISCOMFORT (feels like there is grit in his eye) and CHILLS (Chills but no fever) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.